Skip to main content
Top
Published in: BMC Nephrology 1/2005

Open Access 01-12-2005 | Case report

Does treating obesity stabilize chronic kidney disease?

Authors: Sujata Agnani, Vidula T Vachharajani, Rohit Gupta, Naveen K Atray, Tushar J Vachharajani

Published in: BMC Nephrology | Issue 1/2005

Login to get access

Abstract

Background

Obesity is a growing health issue in the Western world. Obesity, as part of the metabolic syndrome adds to the morbidity and mortality. The incidence of diabetes and hypertension, two primary etiological factors for chronic renal failure, is significantly higher with obesity. We report a case with morbid obesity whose renal function was stabilized with aggressive management of his obesity.

Case report

A 43-year old morbidly obese Caucasian male was referred for evaluation of his chronic renal failure. He had been hypertensive with well controlled blood pressure with a body mass index of 46 and a baseline serum creatinine of 4.3 mg/dl (estimated glomerular filtration rate of 16 ml/min). He had failed all conservative attempts at weight reduction and hence was referred for a gastric by-pass surgery. Following the bariatric surgery he had approximately 90 lbs. weight loss over 8-months and his serum creatinine stabilized to 4.0 mg/dl.

Conclusion

Obesity appears to be an independent risk factor for renal failure. Targeting obesity is beneficial not only for better control of hypertension and diabetes, but also possibly helps stabilization of chronic kidney failure.
Appendix
Available only for authorised users
Literature
1.
go back to reference Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002, 288: 1723-1727. 10.1001/jama.288.14.1723.CrossRefPubMed Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002, 288: 1723-1727. 10.1001/jama.288.14.1723.CrossRefPubMed
2.
go back to reference Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L: Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003, 138: 24-32.CrossRefPubMed Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L: Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003, 138: 24-32.CrossRefPubMed
3.
go back to reference Colditz GA, Willett WC, Rotnitzky A, Manson JE: Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995, 122: 481-CrossRefPubMed Colditz GA, Willett WC, Rotnitzky A, Manson JE: Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med. 1995, 122: 481-CrossRefPubMed
4.
go back to reference Garrison RJ, Kannel WB, Stokes J, et al: Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med. 1987, 16: 235-251. 10.1016/0091-7435(87)90087-9.CrossRefPubMed Garrison RJ, Kannel WB, Stokes J, et al: Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med. 1987, 16: 235-251. 10.1016/0091-7435(87)90087-9.CrossRefPubMed
5.
go back to reference Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH: Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA. 1995, 273: 461-465. 10.1001/jama.273.6.461.CrossRefPubMed Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH: Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA. 1995, 273: 461-465. 10.1001/jama.273.6.461.CrossRefPubMed
6.
go back to reference Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995, 854: 1-452. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995, 854: 1-452.
7.
go back to reference Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults – The Evidence Report. National Institutes of Health. Obes Res. 1998, 2 (supple 6): 51S-209S. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults – The Evidence Report. National Institutes of Health. Obes Res. 1998, 2 (supple 6): 51S-209S.
8.
go back to reference Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA, Kuo JJ, Tallam L: Is Obesity a Major Cause of Chronic Kidney Disease?. Adv Ren Replace Ther. 2004, 11 (1): 41-54. 10.1053/j.arrt.2003.10.007.CrossRefPubMed Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA, Kuo JJ, Tallam L: Is Obesity a Major Cause of Chronic Kidney Disease?. Adv Ren Replace Ther. 2004, 11 (1): 41-54. 10.1053/j.arrt.2003.10.007.CrossRefPubMed
9.
go back to reference Hall JE, Kuo JJ, Silva A, et al: Obesity, hypertension, and renal disease. Curr Opin Nephrol Hypertens. 2003, 12: 195-200. 10.1097/00041552-200303000-00011.CrossRefPubMed Hall JE, Kuo JJ, Silva A, et al: Obesity, hypertension, and renal disease. Curr Opin Nephrol Hypertens. 2003, 12: 195-200. 10.1097/00041552-200303000-00011.CrossRefPubMed
10.
go back to reference Hall JE, Brands MW, Dixon WN, et al: Obesity-induced hypertension: Renal function and systemic hemodynamics. Hypertension. 1993, 22: 292-299.CrossRefPubMed Hall JE, Brands MW, Dixon WN, et al: Obesity-induced hypertension: Renal function and systemic hemodynamics. Hypertension. 1993, 22: 292-299.CrossRefPubMed
11.
go back to reference Chagnac A, Weinstein T, Korzets A, et al: Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000, 278: F817-F822.PubMed Chagnac A, Weinstein T, Korzets A, et al: Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol. 2000, 278: F817-F822.PubMed
12.
go back to reference Hall JE, Jones DW, Henegar J, et al: Obesity, hypertension and renal disease. In Obesity: Mechanisms and Clinical Management. Edited by: Eckel RH. 2003, Lippincott, Williams & Wilkins, Philadelphia, PA, 273-300. Hall JE, Jones DW, Henegar J, et al: Obesity, hypertension and renal disease. In Obesity: Mechanisms and Clinical Management. Edited by: Eckel RH. 2003, Lippincott, Williams & Wilkins, Philadelphia, PA, 273-300.
13.
go back to reference Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J: Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res. 2003, 11: 525-531.CrossRefPubMed Bullo M, Garcia-Lorda P, Megias I, Salas-Salvado J: Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res. 2003, 11: 525-531.CrossRefPubMed
14.
go back to reference Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, Nawata H: Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med. 2004, 37: 115-123. 10.1016/j.freeradbiomed.2004.04.001.CrossRefPubMed Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, Nawata H: Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med. 2004, 37: 115-123. 10.1016/j.freeradbiomed.2004.04.001.CrossRefPubMed
15.
go back to reference Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001, 59 (4): 1498-509. 10.1046/j.1523-1755.2001.0590041498.x.CrossRefPubMed Kambham N, Markowitz GS, Valeri AM, Lin J, D'Agati VD: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int. 2001, 59 (4): 1498-509. 10.1046/j.1523-1755.2001.0590041498.x.CrossRefPubMed
16.
go back to reference Pories WJ, Swanson M, MacDonald KG, Long SD, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L: Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995, 222: 339-352.CrossRefPubMedPubMedCentral Pories WJ, Swanson M, MacDonald KG, Long SD, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L: Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg. 1995, 222: 339-352.CrossRefPubMedPubMedCentral
17.
go back to reference Pinkney JH, Sjostrom CD, Gale EAM: Should surgeons treat diabetes in very obese people?. Lancet. 2001, 357: 1357-1359. 10.1016/S0140-6736(00)04524-4.CrossRefPubMed Pinkney JH, Sjostrom CD, Gale EAM: Should surgeons treat diabetes in very obese people?. Lancet. 2001, 357: 1357-1359. 10.1016/S0140-6736(00)04524-4.CrossRefPubMed
18.
go back to reference Alexander JW, Goodman HR, Gersin K, Cardi M, Austin J, Goel S, Safdar S, Huang S, Woodle ES: Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant. Transplantation. 2004, 78 (3): 469-74. 10.1097/01.TP.0000128858.84976.27.CrossRefPubMed Alexander JW, Goodman HR, Gersin K, Cardi M, Austin J, Goel S, Safdar S, Huang S, Woodle ES: Gastric bypass in morbidly obese patients with chronic renal failure and kidney transplant. Transplantation. 2004, 78 (3): 469-74. 10.1097/01.TP.0000128858.84976.27.CrossRefPubMed
Metadata
Title
Does treating obesity stabilize chronic kidney disease?
Authors
Sujata Agnani
Vidula T Vachharajani
Rohit Gupta
Naveen K Atray
Tushar J Vachharajani
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2005
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-6-7

Other articles of this Issue 1/2005

BMC Nephrology 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.